← Back to Search

External and Internal Facilitation (NOCTEM+EF/IF) for Chronic Insomnia

N/A
Waitlist Available
Research Sponsored by Noctem, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-month follow-up
Awards & highlights

Study Summary

This trial will compare three ways to use NOCTEM COAST, a decision-support platform, with behavioral health providers who see patients with insomnia.

Who is the study for?
This trial is for behavioral health care providers who have recently completed a Behavioral Sleep Medicine workshop and see patients with insomnia. Providers must use cognitive-behavioral techniques, work at participating sites, and their patients should own a smart device and be willing to use the NOCTEM app.Check my eligibility
What is being tested?
The study compares three methods of implementing the NOCTEM COAST platform among providers treating insomnia: external facilitation support, no facilitation support, or both external and internal support. It aims to optimize how this digital tool is used in clinical practice.See study design
What are the potential side effects?
Since this trial involves the implementation of a digital health platform rather than medication or medical procedures, traditional side effects are not applicable. However, there may be technical issues or challenges in using the app that could affect user experience.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adoption among clinicians randomized to NOCTEM only, NOCTEM+EF, or NOCTEM+EF/IF
Change in Insomnia Severity Index
Maintenance (sustainability) among clinicians randomized to NOCTEM only, NOCTEM+EF, or NOCTEM+EF/IF
+1 more

Trial Design

3Treatment groups
Active Control
Group I: External and Internal Facilitation (NOCTEM+EF/IF)Active Control1 Intervention
External and internal facilitation
Group II: External Facilitation (NOCTEM+EF)Active Control1 Intervention
External facilitation only
Group III: NOCTEM only (NOCTEM)Active Control1 Intervention
No external or internal facilitation

Find a Location

Who is running the clinical trial?

Noctem, LLCLead Sponsor
1 Previous Clinical Trials
188 Total Patients Enrolled
United States Department of DefenseFED
865 Previous Clinical Trials
327,682 Total Patients Enrolled
US Air Force Medical Readiness AgencyUNKNOWN

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this clinical trial actively seeking participants at the moment?

"As per the details on clinicaltrials.gov, recruitment for this particular trial has ceased. It was initially made available on 1st of September 2020 and last updated on 2nd of March 2021. Despite its closure, there are currently 210 alternative studies actively seeking participants."

Answered by AI
~4 spots leftby May 2025